-+ 0.00%
-+ 0.00%
-+ 0.00%

Joint Laboratories International Inc.: Received a milestone payment of $9 million from Novo Nordisk for UBT251's global phase II clinical trial.

智通財經·09/24/2026 15:01:18
語音播報
Joint Laboratories International Inc.: Received a milestone payment of $9 million from Novo Nordisk for UBT251's global phase II clinical trial.